BAKER-GLENN, Charles,BURDICK, Daniel Jon,CHAMBERS, Mark,CHEN, Huifen,ESTRADA, Anthony,SWEENEY, Zachary Kevin,CHAN, Bryan K.
申请号：
ES16180927
公开号：
ES2746134T3
申请日:
2011.11.09
申请国别(地区):
ES
年份:
2020
代理人:
摘要：
Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein X, R 1 , R 2 , R 3 , R 4 and R 5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
